Simple Summary Active surveillance is a strategy used to manage early-stage prostate
cancer without immediate treatment, aiming to maintain patients' quality of life. However …

Background Based on the findings of different trials in biopsy naïve patients, target biopsy
(TB) plus random biopsy (RB) during mpMRI-guided transrectal ultrasound fusion biopsy …

Background Cribriform (CF) and/or intraductal carcinoma (IDC) are associated with more
aggressive prostate cancer (CaP) and worse outcomes. Objective The transcriptomic …

Abstract Purpose Recently, Eggener et al. reignited a debate consisting to redefine Gleason
Grade Group (GGG) 1 prostate cancer (PCa) as a precancerous lesion to reduce …

Importance Although tissue-based gene expression testing has become widely used for
prostate cancer risk stratification, its prognostic performance in the setting of clinical care is …

Simple Summary AS is an option for the initial management of selected patients with
intermediate-risk PC. The proper way to predict which men will have an aggressive clinical …

Abstract Introduction and Objectives To investigate the additive role of prostate‐specific
membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) …

Background/Aim: To evaluate the long-term oncological outcomes in men with intermediate
risk prostate cancer (PCa) enrolled in active surveillance (AS). Patients and Methods: From …

Background Tissue‐based gene expression (genomic) tests provide estimates of prostate
cancer aggressiveness and are increasingly used for patients considering or engaged in …

Introduction Biomarkers for prostate cancer, such as multiparametric MRI (mpMRI) and
tissue-based genomics, are increasingly used for treatment decision-making. Using …